| Mrs Deborah Abril Medina, MASTER D | |
|
Carr. #2 Edificio Professional Plaza, Suite 203, Isabela, PR 00662 | |
| (787) 872-1717 | |
| (787) 872-1717 |
| Full Name | Mrs Deborah Abril Medina |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | Carr. #2 Edificio Professional Plaza, Isabela, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033252358 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 2018 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Deborah Abril Medina, MASTER D 1312 Felix Aldarondo Ave., Pmb 487, Isabela, PR 00662 Ph: (787) 872-1717 | Mrs Deborah Abril Medina, MASTER D Carr. #2 Edificio Professional Plaza, Suite 203, Isabela, PR 00662 Ph: (787) 872-1717 |
News Archive
Research led by Dr. Jay Kolls, Professor and Chairman of Genetics at LSU Health Sciences Center New Orleans, has identified a therapeutic target for acute lung injury resulting in acute respiratory distress syndrome, a highly fatal complication of influenza infection.
Two new policy research briefs analyze health centers' growth over the past two decades and Medicaid's role in propelling and sustaining that growth. The analyses chronicle federal health center growth initiatives pursued by Republican and Democratic Administrations alike, as well as the 2011 retrenchment in the growth trajectory.
A collaborative research team led by scientists at Houston Methodist is one step closer to developing technologies that could help mend broken bones faster. The Department of Defense awarded close to $6 million to the Houston Methodist Research Institute for an initiative aimed at studying two new materials to repair complex fractures in long bones.
A new theory of how cancer works could lead to the next generation of treatments of the disease. The theory suggests that cancer forms when recently evolved genes are damaged, and cells have to revert to using older, inappropriate genetic pathways.
Celator Pharmaceuticals today announced that it has completed enrollment in its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML).
› Verified 9 days ago
Dr. Francheska M Mendoza Santiago, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 133 Calle Dr Gonzalez, Isabela, PR 00662 Phone: 787-872-5565 | |
Lydia Isabel Rios, PHD. Psychologist Medicare: Not Enrolled in Medicare Practice Location: Ave. Agustin Ramos Calero #7342 Car. 112 Km 2.3, Barrio Guerrero, Isabela, PR 00662 Phone: 787-341-0143 | |
Mrs. Yelianne Mari Afanador Gonzalez, MS Psychologist Medicare: Not Enrolled in Medicare Practice Location: 79 Calle Dr Gonzalez, Isabela, PR 00662 Phone: 939-418-3364 | |
Lorraine Marie Rios, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: Ave. Agustin Ramos Calero #7342 Car. 112 Km 2.3, Barrio Guerrero, Isabela, PR 00662 Phone: 787-341-2072 | |
Mrs. Catherine Ramos, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2839ave Militar, Hill Plaza, Isabela, PR 00662 Phone: 787-363-1712 | |
Omar Antonio Samot Cruz Sr., Psychologist Medicare: Medicare Enrolled Practice Location: 121 Ruta 474, Isabela, PR 00662 Phone: 939-323-0563 |